FLGR242 vs igf-1 lr3

FLGR242 (F-tier) vs igf-1 lr3 (F-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

FLGR242 · tier F

FLGR242 is a seller name for a claimed follistatin-albumin construct. The seller now publishes partial specifications, but the complete construct and independent characterization remain unresolved.

The market description is now more specific, but it still does not establish a reproducible complete construct or the marketed 19-day pharmacokinetic claim.

0 independent characterizations located · half-life unknown; marketed 19-day claim lacks compound-specific PK

igf-1 lr3 · tier F

a free-circulating IGF-1 analog for muscle growth. sustained IGF-1 elevation carries one of the clearer cancer-risk signals in the literature.

a free-circulating IGF-1 analog. anabolic signal is real; sustained IGF-1 elevation carries one of the clearer cancer-risk signals in the literature.

WADA S2 banned in sport · half-life ~1-2 hours, estimated (no human PK); NOT long-acting, LR3 escapes the IGF-binding proteins that give complex-bound native IGF-1 its ~12-15h half-life · growth hormone

at a glance

• FLGR242: tier F · 0 independent characterizations located
• igf-1 lr3: tier F · WADA S2 banned in sport

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.